IFG Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

IFG Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8K	Buy	+375	New	+$11.9K	﹤0.01%	1719
2022 Q2	–	Sell	-5,261	Closed	-$241K	–	463
2022 Q1	$241K	Buy	5,261 +167	+3%	+$7.96K	0.02%	441
2021 Q4	$312K	Buy	5,094 +577	+13%	+$39.9K	0.03%	397
2021 Q3	$337K	Buy	4,517 +1,245	+38%	+$104K	0.04%	374
2021 Q2	$302K	Sell	3,272 -45	-1%	-$3.83K	0.03%	390
2021 Q1	$294K	Buy	+3,317	New	+$329K	0.04%	396

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

IFG Advisory's ARKG Position: Q2 2026 in Review

IFG Advisory opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 375 shares worth $15.8K. The stake represents ﹤0.01% of the portfolio and ranks #1719 among its holdings. This is a return to the name: IFG Advisory previously reported a position in ARKG as recently as Q1 2022.

IFG Advisory first reported a position in ARKG in Q1 2021 and has held it in 6 quarters since. The position peaked at $337K in Q3 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

IFG Advisory held 375 shares of ARK Genomic Revolution ETF worth $15.8K as of Q2 2026.
ARK Genomic Revolution ETF was a new IFG Advisory position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #1719 holding.
IFG Advisory first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 6 quarters since.
IFG Advisory's ARK Genomic Revolution ETF position peaked at $337K in Q3 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.